Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants

Clinical trial NCT00197275 · COMPLETED

Trial details

NCT number: NCT00197275
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tetanus Hepatitis B Haemophilus Influenzae Type b Whole Cell Pertussis Diphtheria

Start date: 2006-02-01
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.